{"id":20212,"date":"2025-08-29T11:21:34","date_gmt":"2025-08-29T11:21:34","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=20212"},"modified":"2025-08-29T11:21:34","modified_gmt":"2025-08-29T11:21:34","slug":"celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/","title":{"rendered":"\u30bb\u30ec\u30a4\u30c9\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3068AGC\u304ciPS\u7d30\u80de-HSPC\u7814\u7a76\u5951\u7d04\u3092\u7de0\u7d50"},"content":{"rendered":"<p>\u30bb\u30ec\u30a4\u30c9\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u30bb\u30ec\u30a4\u30c9\u793e\u306f\u3001AGC \u793e\u3068\u5171\u540c\u7814\u7a76\u5951\u7d04\u3092\u7de0\u7d50\u3057\u307e\u3057\u305f\u3002AGC\u306f\u3001\u4eba\u5de5\u591a\u80fd\u6027\u5e79\u7d30\u80de\uff08iPSC-HSPCs\uff09\u304b\u3089\u306e\u9020\u8840\u5e79\u7d30\u80de\u304a\u3088\u3073\u524d\u99c6\u7d30\u80de\u306e\u958b\u767a\u306b\u6ce8\u529b\u3057\u3066\u3044\u307e\u3059\u3002\u4eca\u56de\u306e\u63d0\u643a\u306f\u3001\u30bb\u30ec\u30a4\u30c9\u793e\u72ec\u81ea\u306e\u9020\u8840\u5e79\u7d30\u80de\uff08HSC\uff09\u62e1\u5927\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068AGC\u793e\u306eiPSC\u6280\u8853\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001iPSC-HSPC\u306e\u3088\u308a\u826f\u3044\u3001\u3088\u308a\u5927\u898f\u6a21\u306a\u5897\u6b96\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>Celaid\u793e\u306e\u9020\u8840\u5e79\u7d30\u80de\u62e1\u5927\u6280\u8853\u306f\u3001AGC\u793e\u306eiPSC-HSPCs\u3068\u5171\u306b\u4f7f\u7528\u3055\u308c\u307e\u3059\u3002\u62e1\u5927\u3055\u308c\u305f\u7d30\u80de\u306f\u3001\u7814\u7a76\u5ba4\u3084\u52d5\u7269\u5b9f\u9a13\u3067\u6a5f\u80fd\u6027\u304c\u691c\u8a3c\u3055\u308c\u307e\u3059\u3002\u3053\u306e\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u306f\u3001\u9ad8\u54c1\u8cea\u306eiPSC-HSPC\u3092\u5927\u91cf\u751f\u7523\u3059\u308b\u65b9\u6cd5\u306e\u78ba\u7acb\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002iPSC\u3092\u7528\u3044\u305f\u8840\u6db2\u30fb\u514d\u75ab\u7d30\u80de\u7642\u6cd5\u306e\u958b\u767a\u306b\u304a\u3051\u308b\u88fd\u9020\u4e0a\u306e\u91cd\u8981\u306a\u8ab2\u984c\u306b\u53d6\u308a\u7d44\u3080\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/asahi-kasei-opens-new-plant-to-boost-planova-output\/\" rel=\"bookmark\">\u65ed\u5316\u6210\u3001\u30d7\u30e9\u30ce\u30d0\u751f\u7523\u5897\u5f37\u306e\u305f\u3081\u65b0\u5de5\u5834\u3092\u958b\u8a2d<\/a><\/h4>\n<p>\u300c\u79c1\u305f\u3061\u306f <a href=\"https:\/\/www.agc.com\/\">\u81ea\u52d5\u5229\u5f97\u5236\u5fa1<\/a>.\u8352\u5ddd\u4fe1\u884c\u793e\u9577\u517cCEO\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u79c1\u305f\u3061\u306f\u3001\u5148\u9032\u7684\u306a\u5e79\u7d30\u80de\u6280\u8853\u3092\u7528\u3044\u3066\u3001\u5c06\u6765\u306e\u98db\u8e8d\u7684\u306a\u9032\u6b69\u3092\u76ee\u6307\u3057\u307e\u3059\u3002 <a href=\"https:\/\/celaidtx.com\/\">\u30bb\u30ec\u30a4\u30c9\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/a>.\"\u4eca\u56de\u306e\u5171\u540c\u7814\u7a76\u306f\u3001iPSC\u7531\u6765\u306e\u9020\u8840\u7d30\u80de\u30fb\u514d\u75ab\u7d30\u80de\u6cbb\u7642\u88fd\u54c1\u306e\u88fd\u9020\u306b\u304a\u3051\u308b\u4e3b\u306a\u8ab2\u984c\u306e\u89e3\u6c7a\u306b\u5411\u3051\u305f\u5927\u304d\u306a\u4e00\u6b69\u3067\u3059\u3002\"<\/p>","protected":false},"excerpt":{"rendered":"<p>Celaid Therapeutics Inc. Celaid has teamed up with AGC Inc. for a collaborative research agreement. AGC focuses on advancing hematopoietic stem and progenitor cells from induced pluripotent stem cells (iPSC-HSPCs). The partnership aims to combine Celaid\u2019s unique hematopoietic stem cell (HSC) expansion platform with AGC\u2019s iPSC technology. This will allow for better and larger-scale growth of iPSC-HSPCs. Celaid\u2019s HSC expansion technology will be used with AGC\u2019s iPSC-HSPCs. The expanded cells will then be tested for functionality in the lab and in animal studies. The initiative seeks to create a way for large-scale production of high-quality iPSC-HSPCs. It aims to tackle important manufacturing challenges in developing iPSC-based blood and immune cell [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":20213,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[7466,150,7467,7469,7468],"ppma_author":[572],"class_list":{"0":"post-20212","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-biotech","9":"category-health-tech","10":"category-japan","11":"category-news","12":"category-regional","13":"tag-agc","14":"tag-biotech","15":"tag-celaid-therapeutics","16":"tag-hsc-expansion-technology","17":"tag-ipsc-technology"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celaid Therapeutics, AGC Ink iPSC-HSPC Research Deal<\/title>\n<meta name=\"description\" content=\"Celaid Therapeutics and AGC to advance scalable iPSC-HSPC expansion, combining stem cell and iPSC technologies for next-gen therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celaid Therapeutics, AGC Ink iPSC-HSPC Research Deal\" \/>\n<meta property=\"og:description\" content=\"Celaid Therapeutics and AGC to advance scalable iPSC-HSPC expansion, combining stem cell and iPSC technologies for next-gen therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T11:21:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Celaid-Therapeutics-have-executed-a-collaborative-research-agreement-with-AGC-on-Expansion-and-Functional-Evaluation-of-iPSC-HSPCs.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30bb\u30ec\u30a4\u30c9\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3068AGC\u304ciPS\u7d30\u80de-HSPC\u7814\u7a76\u5951\u7d04\u3092\u7de0\u7d50","description":"\u30bb\u30ec\u30a4\u30c9\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3068AGC\u793e\u3001\u5e79\u7d30\u80de\u3068iPS\u7d30\u80de\u306e\u6280\u8853\u3092\u878d\u5408\u3057\u305f\u6b21\u4e16\u4ee3\u6cbb\u7642\u306e\u305f\u3081\u306e\u62e1\u5f35\u53ef\u80fd\u306aiPSC-HSPC\u6a39\u7acb\u3092\u63a8\u9032.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/","og_locale":"ja_JP","og_type":"article","og_title":"Celaid Therapeutics, AGC Ink iPSC-HSPC Research Deal","og_description":"Celaid Therapeutics and AGC to advance scalable iPSC-HSPC expansion, combining stem cell and iPSC technologies for next-gen therapies.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/","og_site_name":"itbusinesstoday","article_published_time":"2025-08-29T11:21:34+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Celaid-Therapeutics-have-executed-a-collaborative-research-agreement-with-AGC-on-Expansion-and-Functional-Evaluation-of-iPSC-HSPCs.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Celaid Therapeutics and AGC sign iPSC-HSPC research deal","datePublished":"2025-08-29T11:21:34+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/"},"wordCount":182,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Celaid-Therapeutics-have-executed-a-collaborative-research-agreement-with-AGC-on-Expansion-and-Functional-Evaluation-of-iPSC-HSPCs.webp","keywords":["AGC","Biotech","Celaid Therapeutics","HSC expansion technology","iPSC technology"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/","name":"\u30bb\u30ec\u30a4\u30c9\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3068AGC\u304ciPS\u7d30\u80de-HSPC\u7814\u7a76\u5951\u7d04\u3092\u7de0\u7d50","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Celaid-Therapeutics-have-executed-a-collaborative-research-agreement-with-AGC-on-Expansion-and-Functional-Evaluation-of-iPSC-HSPCs.webp","datePublished":"2025-08-29T11:21:34+00:00","description":"\u30bb\u30ec\u30a4\u30c9\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3068AGC\u793e\u3001\u5e79\u7d30\u80de\u3068iPS\u7d30\u80de\u306e\u6280\u8853\u3092\u878d\u5408\u3057\u305f\u6b21\u4e16\u4ee3\u6cbb\u7642\u306e\u305f\u3081\u306e\u62e1\u5f35\u53ef\u80fd\u306aiPSC-HSPC\u6a39\u7acb\u3092\u63a8\u9032.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Celaid-Therapeutics-have-executed-a-collaborative-research-agreement-with-AGC-on-Expansion-and-Functional-Evaluation-of-iPSC-HSPCs.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Celaid-Therapeutics-have-executed-a-collaborative-research-agreement-with-AGC-on-Expansion-and-Functional-Evaluation-of-iPSC-HSPCs.webp","width":1200,"height":800,"caption":"Celaid Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-and-agc-sign-ipsc-hspc-research-deal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Celaid Therapeutics and AGC sign iPSC-HSPC research deal"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=20212"}],"version-history":[{"count":2,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20212\/revisions"}],"predecessor-version":[{"id":20221,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20212\/revisions\/20221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/20213"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=20212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=20212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=20212"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=20212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}